Vietnam Medical Nutrition Market Research, 2035

The Vietnam medical nutrition market size was valued at $0.09 billion in 2023, and is projected to reach $0.16 billion by 2035, registering a CAGR of 5.3% from 2024 to 2035. The growth of the Vietnam medical nutrition market is driven by rise in demand for enteral and oral nutrition. For instance, Abbott, formed strategic partnerships with the Departments of Vietnam Ministry of Health (MOH) and the Asia-Pacific Economic Cooperation (APEC) for long-term improvements to public healthcare. The company’s support on MOH and APEC health initiatives (including food safety, maternal health, and clinical nutrition) led the MOH to grant Abbott an MOH Award recognizing the company’s contributions in Vietnam.

Medical nutrition is a specialized field dedicated to using targeted dietary interventions to manage medical conditions and improve health outcomes. It focuses on developing and administering nutritional products tailored to meet the specific needs of individuals dealing with chronic illnesses, malnutrition, or metabolic disorders. These products provide essential nutrients, vitamins, and minerals to support physiological functions, boost immune response, and aid in recovery. By optimizing metabolic pathways, enhancing nutrient absorption, and preventing disease-related complications, medical nutrition helps manage symptoms and improve patients' quality of life.

Key Takeaways

• On the basis of product type, the enteral & oral nutrition segment dominated the market share in 2023 and is anticipated to grow at the highest CAGR during the forecast period.
• On the basis of application, the others segment dominated the market share in 2023. However, the cancer segment is anticipated to grow at the highest CAGR during the forecast period.
• On the basis of end user, the home care segment dominated the market share in 2023 and is anticipated to grow at the highest CAGR during the forecast period.
•  On the basis of distribution channel, the drug store and retail pharmacies segment dominated the market share in 2023. However, online providers segment is anticipated to grow at the highest CAGR during the forecast period.

Market Dynamics

The Vietnam medical nutrition market is experiencing robust growth driven by several key factors, including rising healthcare awareness, increasing prevalence of chronic diseases, and strategic partnerships among industry players. One of the primary drivers is the growing incidence of chronic conditions, such as cancer and diabetes. According to the World Health Organization (WHO) report in 2022, Vietnam recorded 180,480 new cancer cases, which underscores the urgent need for specialized nutritional support to maintain the strength of patients during treatment. The increasing prevalence of diabetes, as highlighted by the International Diabetes Federation (IDF), further amplifies the demand for medical nutrition products. In 2021, approximately 3,994.1 thousand individuals in Vietnam were reported to have diabetes, with projections indicating a rise to 6,015.3 thousand by 2045. These statistics indicate a substantial market opportunity for medical nutritional products tailored to these specific health challenges, as patients require dietary interventions to manage their conditions effectively.

However, the Vietnam medical nutrition market pose significant challenges. One of the primary obstacles is the lack of awareness regarding the importance of medical nutrition among both healthcare providers and patients. Many individuals in Vietnam still view nutritional products as supplementary rather than essential components of their health regimen, which can limit market penetration. Additionally, there may be regulatory hurdles that affect the availability and approval of medical nutrition products, potentially leading to delays in product launches and limiting access to essential therapies for patients. The overall healthcare infrastructure in Vietnam, while improving, still faces challenges in terms of capacity and accessibility, particularly in rural areas where healthcare services are less developed. This situation can hinder the effective distribution of medical nutrition products and reduce their reach among the populations that need them most.

Despite these challenges, there are significant opportunities for growth within the Vietnam medical nutrition market. The presence of key players offering medical nutritional products, along with growing initiatives through partnerships and collaborations, is contributing positively to Vietnam medical nutrition market expansion. For instance, Abbott has forged strategic partnerships with the Departments of Vietnam's Ministry of Health (MOH) and the Asia-Pacific Economic Cooperation (APEC) to foster long-term improvements in public healthcare. Abbott's involvement in health initiatives focusing on food safety, maternal health, and clinical nutrition has not only led to the company receiving an MOH Award for its contributions in Vietnam but also elevated healthcare standards in the country. These partnerships enhance the visibility and credibility of medical nutrition products, thereby promoting their adoption among healthcare providers and patients alike.

The growing awareness of the importance of preventive healthcare also presents a lucrative opportunity for the medical nutrition market in Vietnam. As the population becomes more health-conscious, there is a greater willingness to invest in products that enhance overall health and well-being. This trend is particularly evident among the aging population, which is increasingly seeking nutritional solutions to address age-related health concerns. Additionally, as the Vietnamese economy continues to grow, disposable incomes are rising, allowing consumers to invest more in health products, including medical nutrition solutions.

Moreover, innovation in product development presents a significant growth opportunity for the Vietnam medical nutrition market. Companies that prioritize research and development can formulate specialized nutritional products designed to meet the specific needs of diverse patient populations, particularly those with chronic diseases. By focusing on evidence-based nutrition, these companies can build credibility among healthcare professionals, who are more inclined to endorse products supported by clinical research. This emphasis on tailored solutions not only addresses the unique health challenges faced by patients but also aligns with the broader trend towards personalized medicine, enhancing the overall effectiveness and adoption of medical nutrition products within the healthcare system.

Segmental Overview

The Vietnam medical nutrition market is segmented into product type, application, end user, and distribution channel. On the basis of product type, it is segmented into infant nutrition, parenteral nutrition, and enteral & oral nutrition. The parenteral nutrition segment is further categorized into dextrose-based products, fat-based products, and additives-based products. The enteral & oral nutrition segment is further categorized into standardized, semi elemental, and specialized. On the basis of application, the market is classified into diabetes, cancer, gastrointestinal diseases, chronic kidney disease, chronic liver disease, intensive care, chronic obstructive pulmonary disease, and others. The cancer segment is further divided into infants and children, adults and geriatric. The others segment is further segmented into phenylketonuria, tyrosinemia, homocystinuria, isovaleric acidemia, maple syrup urine disease, intractable epilepsy, allergies and rest of all other diseases. As per end user, it is divided into private hospitals, public hospitals and home care. On the basis of distribution channel, the Vietnam medical nutrition market is divided into hospital pharmacies, drug store & retail pharmacies, and online providers.

By Product

The enteral & oral nutrition segment dominated the market share in 2023 and is expected to register the highest CAGR during the forecast period owing to its effectiveness in delivering nutrition orally and directly to the gastrointestinal tract. This approach supports natural digestion processes and is increasingly favored for patients with functional GI tracts. It improves nutrient absorption, lowers infection risks compared to parenteral methods, and aids in overall recovery by promoting a more physiological digestive environment and enhancing patient comfort during nutritional therapy.

[PRODUCTGRAPH]

By Application

The others segment dominated the market share in 2023. The growth of the medical nutrition market is driven by increasing awareness and diagnosis of rare metabolic disorders that require specialized nutritional products for effective management and symptom relief. Advancements in genetic screening and the greater availability of targeted nutritional solutions specifically designed for these disorders are further propelling demand in this segment, contributing to its significant growth rate and enhancing treatment outcomes for affected patients.

However, the cancer segment is expected to register the highest CAGR during the forecast period. This demand is driven by the need for specialized nutritional support in cancer patients. Nutritional products play a vital role in managing treatment-related side effects, boosting immune function, and preserving body weight and muscle mass during therapy. This support is crucial for helping cancer patients tolerate and recover from treatments like chemotherapy and radiation, fueling significant demand in this segment.

[APPLICATIONGRAPH]

By End User

The homecare segment dominated the market in 2023 and is expected to register the highest CAGR during the forecast period. This growth is fueled by rising demand for at-home treatment options, as patients increasingly prioritize convenience and comfort, especially for long-term care. Homecare solutions ease the strain on healthcare facilities, making them a preferred option for managing chronic conditions, rehabilitation, and elderly care, further driving market expansion.

[ENDUSERGRAPH]

By Distribution Channel

The drug store & retail pharmacies segment dominated the market in 2023. This is due to the wide availability and accessibility of these outlets, making it convenient for consumers to obtain medical nutrition products. Drug stores and pharmacies also enjoy strong customer trust and offer personalized service, fostering repeat purchases. Additionally, their knowledgeable staff can guide customers effectively, further positioning them as a preferred source for nutritional products.

However, the online providers segment is expected to register the highest CAGR during the forecast period owing to growing shift toward digital healthcare solutions and the convenience they provide. Demand for medical nutrition products through e-commerce platforms is increasing as consumers become more accustomed to online shopping. Online providers offer a broad selection of medical nutrition products, frequently at competitive prices, making them an appealing option for consumers looking for both affordability and convenience.

Competition Analysis

Competitive analysis and profiles of the major players in the Vietnam medical nutrition market include Abbott Laboratories, B.Braun SE, Baxter International Inc., Fresenius SE & Co. KGaA, Nestle S.A, Nutifood, Reckitt Benckiser Group PLC, Danone, Dutch Medical Food, and Otsuka Holdings Co., Ltd. The key players have adopted various strategies, such as agreement, to strengthen their service portfolio.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments

1.2.1.List of key players profiled in the report

1.3.Key benefits for stakeholders
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.3.1.Bargaining power of buyers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of new entrants
3.3.4.Threat of substitution
3.3.5.Intensity of competitive rivalry

3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Rising prevalence of chronic diseases
3.4.1.2.Growing aging population
3.4.1.3.Rise in adoption of medical nutrition products in Vietnam

3.4.2.Restraint

3.4.2.1.Rural infrastructure and dietary preferences restrain growth

3.4.3.Opportunity

3.4.3.1.Growth opportunity in emerging market

3.5.Impact analysis
3.6.Product Information (Function, Nutritional information, Price)

CHAPTER 4:VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Infant Nutrition

4.2.1.Key market trends and opportunities

4.3.Parenteral Nutrition

4.3.1.Key market trends and opportunities
4.3.2.Parenteral Nutrition Vietnam Medical Nutrition Market by type

4.3.2.1.Dextrose-based Products
4.3.2.2.Fat-based Products
4.3.2.3.Additives-based Products

4.4.Enteral and Oral Nutrition

4.4.1.Key market trends and opportunities
4.4.2.Enteral and Oral Nutrition Vietnam Medical Nutrition Market by type

4.4.2.1.Standardized
4.4.2.2.Semi Elemental
4.4.2.3.Specialized

CHAPTER 5:VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Diabetes

5.2.1.Key market trends and opportunities
5.2.2.Market Share Diabetes by distribution channel, 2023

5.3.Cancer

5.3.1.Key market trends and opportunities
5.3.2.Cancer Vietnam Medical Nutrition Market by Age Group

5.3.2.1.Infant
5.3.2.2.Children, Adults & Geriatric

5.3.3.Market share Cancer by distribution channel, 2023

5.4.Gastrointestinal Diseases

5.4.1.Key market trends and opportunities
5.4.2.Market share gastrointestinal diseases by distribution channel, 2023

5.5.Chronic Kidney Disease

5.5.1.Key market trends and opportunities
5.5.2.Market share chronic kidney disease by distribution channel, 2023

5.6.Chronic Liver Disease

5.6.1.Key market trends and opportunities
5.6.2.Market share chronic liver disease by distribution channel, 2023

5.7.Intensive Care

5.7.1.Key market trends and opportunities
5.7.2.Market share intensive care by distribution channel, 2023

5.8.Chronic Obstructive Pulmonary Disease

5.8.1.Key market trends and opportunities
5.8.2.Market share chronic obstructive pulmonary disease by distribution channel, 2023

5.9.Others

5.9.1.Key market trends and opportunities
5.9.2.Others Vietnam Medical Nutrition Market by Type

5.9.2.1.Phenylketonuria
5.9.2.2.Tyrosinemia
5.9.2.3.Homocystinuria
5.9.2.4.Isovaleric Acidemia
5.9.2.5.Mable syrup urine disease
5.9.2.6.Intractable Epilepsy
5.9.2.7.Allergies
5.9.2.8.Rest of all other disease

5.9.3.Market share Others by distribution channel, 2023

CHAPTER 6:VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospital Pharmacies

6.2.1.Key market trends and opportunities
6.3.Drug Store and Retail Pharmacies

6.3.1.Key market trends and opportunities

6.4.Online Providers

6.4.1.Key market trends and opportunities

CHAPTER 7:VIETNAM MEDICAL NUTRITION MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Private Hospitals

7.2.1.Key market trends and opportunities

7.3.Public Hospitals

7.3.1.Key market trends and opportunities

7.4.Homecare

7.4.1.Key market trends and opportunities

CHAPTER 8:COMPETITIVE LANDSCAPE

8.1.Introduction
8.2.Product mapping of top 10 players
8.3.Competitive dashboard
8.4.Competitive heatmap
8.5.Top player positioning

CHAPTER 9:COMPANY PROFILES

9.1.BAXTER INTERNATIONAL INC.

9.1.1.Company overview
9.1.2.Key executives
9.1.3.Company snapshot
9.1.4.Operating business segments
9.1.5.Product portfolio
9.1.6.Business Performance

9.2.FRESENIUS SE & CO. KGAA

9.2.1.Company overview
9.2.2.Key executives
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.Business Performance

9.3.ABBOTT LABORATORIES

9.3.1.Company overview
9.3.2.Key executives
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Business Performance

9.4.B.BRAUN SE

9.4.1.Company overview
9.4.2.Key executives
9.4.3.Company snapshot
9.4.4.Operating business segment
9.4.5.Product portfolio
9.4.6.Business Performance

9.5.NESTLE S.A.

9.5.1.Company overview
9.5.2.Key executives
9.5.3.Company snapshot
9.5.4.Operating business segment
9.5.5.Product portfolio
9.5.6.Business Performance

9.6.RECKITT BENCKISER GROUP PLC

9.6.1.Company overview
9.6.2.Key executives
9.6.3.Company snapshot
9.6.4.Operating business segments
9.6.5.Product portfolio
9.6.6.Business Performance

9.7.NUTIFOOD

9.7.1.Company overview
9.7.2.Key executive
9.7.3.Company snapshot
9.7.4.Operating business segments
9.7.5.Product portfolio

9.8.DUTCH MEDICAL FOOD

9.8.1.Company overview
9.8.2.Key executives
9.8.3.Company snapshot
9.8.4.Operating business segment
9.8.5.Product portfolio

9.9.DANONE

9.9.1.Company overview
9.9.2.Key executives
9.9.3.Company snapshot
9.9.4.Operating business segment
9.9.5.Product portfolio
9.9.6.Business Performance

9.10.OTSUKA HOLDINGS CO., LTD.

9.10.1.Company overview
9.10.2.Key executives
9.10.3.Company snapshot
9.10.4.Operating business segments
9.10.5.Product portfolio
9.10.6.Business Performance

LIST OF TABLES

TABLE 01.VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT INFORMATION
TABLE 02.VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT, 2023–2035 ($MILLION)
TABLE 03.PARENTERAL NUTRITION VIETNAM MEDICAL NUTRITION MARKET BY TYPE, 2023-2035 ($MILLION)
TABLE 04.ENTERAL AND ORAL NUTRITION VIETNAM MEDICAL NUTRITION MARKET BY TYPE, 2023-2035 ($MILLION)
TABLE 05.VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION, 2023–2035 ($MILLION)
TABLE 06.DIABETES VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 07.CANCER VIETNAM MEDICAL NUTRITION MARKET BY AGE GROUP, 2023-2035 ($MILLION)
TABLE 08.CANCER VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 09.GASTROINTESTINAL DISEASES VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 10.CHRONIC KIDNEY DISEASE VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 11.CHRONIC LIVER DISEASE VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 12.INTENSIVE CARE VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 13.CHRONIC OBSTRUCTIVE PULMONARY DISEASE VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 14.OTHERS VIETNAM MEDICAL NUTRITION MARKET BY TYPE, 2023-2035 ($MILLION)
TABLE 15.OTHERS VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 16.VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023–2035 ($MILLION)
TABLE 17.VIETNAM MEDICAL NUTRITION MARKET, BY END USER, 2023–2035 ($MILLION)
TABLE 18.BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 19.BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 20.BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
TABLE 21.BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 22.FRESENIUS SE & CO. KGAA: KEY EXECUTIVES
TABLE 23.FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT
TABLE 24.FRESENIUS SE & CO. KGAA: PRODUCT SEGMENTS
TABLE 25.FRESENIUS SE & CO. KGAA: PRODUCT PORTFOLIO
TABLE 26.ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 27.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 28.ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 29.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 30.B.BRAUN SE: KEY EXECUTIVES
TABLE 31.B.BRAUN SE: COMPANY SNAPSHOT
TABLE 32.B.BRAUN SE: PRODUCT SEGMENT
TABLE 33.B.BRAUN SE: PRODUCT PORTFOLIO
TABLE 34.NESTLE S.A.: KEY EXECUTIVES
TABLE 35.NESTLE S.A.: COMPANY SNAPSHOT
TABLE 36.NESTLE S.A.: PRODUCT SEGMENT
TABLE 37.NESTLE S.A.: PRODUCT PORTFOLIO
TABLE 38.RECKITT BENCKISER GROUP PLC: KEY EXECUTIVES
TABLE 39.RECKITT BENCKISER GROUP PLC: COMPANY SNAPSHOT
TABLE 40.RECKITT BENCKISER GROUP PLC: PRODUCT SEGMENTS
TABLE 41.RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
TABLE 42.NUTIFOOD: KEY EXECUTIVE
TABLE 43.NUTIFOOD: COMPANY SNAPSHOT
TABLE 44.NUTIFOOD: PRODUCT SEGMENTS
TABLE 45.NUTIFOOD: PRODUCT PORTFOLIO
TABLE 46.DUTCH MEDICAL FOOD: KEY EXECUTIVES
TABLE 47.DUTCH MEDICAL FOOD: COMPANY SNAPSHOT
TABLE 48.DUTCH MEDICAL FOOD: PRODUCT SEGMENT
TABLE 49.DUTCH MEDICAL FOOD: PRODUCT PORTFOLIO
TABLE 50.DANONE: KEY EXECUTIVES
TABLE 51.DANONE: COMPANY SNAPSHOT
TABLE 52.DANONE: PRODUCT SEGMENT
TABLE 53.DANONE: PRODUCT PORTFOLIO
TABLE 54.OTSUKA HOLDINGS CO., LTD.: KEY EXECUTIVES
TABLE 55.OTSUKA HOLDINGS CO., LTD.: COMPANY SNAPSHOT
TABLE 56.OTSUKA HOLDINGS CO., LTD.: PRODUCT SEGMENTS
TABLE 57.OTSUKA HOLDINGS CO., LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.EXECUTIVE SUMMARY
FIGURE 02.VIETNAM MEDICAL NUTRITION MARKET SEGMENTATION
FIGURE 03.TOP INVESTMENT POCKETS IN VIETNAM MEDICAL NUTRITION MARKET (2023 TO 2035)
FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE THREAT OF SUBSTITUTION
FIGURE 08.LOW COMPETITIVE RIVALRY
FIGURE 09.OPPORTUNITY, RESTRAINT, AND DRIVERS: VIETNAM MEDICAL NUTRITION MARKET
FIGURE 10.VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT, 2023-2035 (%)
FIGURE 11.VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION, 2023-2035 (%)
FIGURE 12.VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2023-2035 (%)
FIGURE 13.VIETNAM MEDICAL NUTRITION MARKET, BY END USER, 2023-2035 (%)
FIGURE 14.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 15.COMPETITIVE DASHBOARD
FIGURE 16.COMPETITIVE HEATMAP: VITENAM MEDICAL NUTRITION MARKET
FIGURE 17.TOP PLAYER POSITIONING, 2023
FIGURE 18.BAXTER INTERNATIONAL INC.: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 19.BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 20.BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 21.FRESENIUS SE & CO. KGAA: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 22.FRESENIUS SE & CO. KGAA: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 23.FRESENIUS SE & CO. KGAA: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 24.ABBOTT LABORATORIES: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 25.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 26.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 27.B.BRAUN SE: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 28.B.BRAUN SE: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 29.B.BRAUN SE: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 30.NESTLE S.A.: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 31.NESTLE S.A..: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 32.NESTLE S.A..: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 33.RECKITT BENCKISER GROUP PLC: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 34.RECKITT BENCKISER GROUP PLC: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 35.RECKITT BENCKISER GROUP PLC: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 36.DANONE: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 37.DANONE: REVENUE SHARE BY REGION, 2023 (%)
FIGURE 38.OTSUKA HOLDINGS CO., LTD.: NET REVENUE, 2021-2023 ($MILLION)
FIGURE 39.OTSUKA HOLDINGS CO., LTD.: REVENUE SHARE BY SEGMENT, 2023 (%)
FIGURE 40.OTSUKA HOLDINGS CO., LTD.: REVENUE SHARE BY REGION, 2023 (%)